Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.48% | 12.27% | -4.96% | 13.67% | 3.03% |
| Total Depreciation and Amortization | -15.67% | -10.97% | -13.95% | -7.49% | -2.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.21% | 125.37% | -57.24% | -485.71% | -210.53% |
| Change in Net Operating Assets | -81.07% | -65.53% | 433.33% | 69.92% | 48.66% |
| Cash from Operations | -42.21% | -11.63% | -10.27% | 27.27% | 71.60% |
| Capital Expenditure | -4.32% | -18.52% | 18.07% | -5.99% | 24.24% |
| Sale of Property, Plant, and Equipment | 200.00% | 54.55% | -69.70% | 300.00% | -33.33% |
| Cash Acquisitions | -- | -- | -244.55% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 89.51% | 2,583.33% | -3,133.33% | 127.59% | -12,150.00% |
| Cash from Investing | 74.04% | 105.32% | -202.96% | 42.89% | 35.39% |
| Total Debt Issued | 135.68% | -100.00% | -100.00% | -100.17% | 17.33% |
| Total Debt Repaid | -- | 33.90% | 25.90% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 33.33% | -- | -- | -- | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.37% | -9.56% | -11.11% | -10.37% | -15.38% |
| Other Financing Activities | -58.72% | -221.43% | 272.22% | 775.00% | 445.00% |
| Cash from Financing | 94.40% | -156.72% | -164.15% | 92.10% | 29.77% |
| Foreign Exchange rate Adjustments | 68.18% | -2,830.00% | 339.73% | -225.00% | 170.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.12% | -132.66% | -180.50% | 554.76% | 48.82% |